• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Ledermann J A, Raja F A, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C

机构信息

UCL Cancer Institute, University College London, London.

出版信息

Ann Oncol. 2013 Oct;24 Suppl 6:vi24-32. doi: 10.1093/annonc/mdt333.

DOI:10.1093/annonc/mdt333
PMID:24078660
Abstract
摘要

相似文献

1
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的上皮性卵巢癌：ESMO 临床实践指南之诊断、治疗及随访
Ann Oncol. 2013 Oct;24 Suppl 6:vi24-32. doi: 10.1093/annonc/mdt333.
2
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的上皮性卵巢癌：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v23-30. doi: 10.1093/annonc/mdq244.
3
Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新发及复发性上皮性卵巢癌：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:21-3. doi: 10.1093/annonc/mdp117.
4
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.原发性乳腺癌：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi7-23. doi: 10.1093/annonc/mdt284. Epub 2013 Aug 22.
5
Epithelial ovarian cancer.上皮性卵巢癌
Obstet Gynecol Clin North Am. 2012 Jun;39(2):269-83. doi: 10.1016/j.ogc.2012.03.003.
6
BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.非黏液性上皮性卵巢癌中的BRCA1/2种系检测：国际实践的变化及对服务提供的影响
Eur J Hum Genet. 2017 Feb;25(2):167-168. doi: 10.1038/ejhg.2016.138. Epub 2016 Oct 19.
7
[Pay more attention to the surveillance and deal with the recurrence in ovarian cancer].[更加关注卵巢癌的监测及复发病例的处理]
Zhonghua Fu Chan Ke Za Zhi. 2003 Nov;38(11):657-8.
8
Follow-up of epithelial ovarian cancer: overdue for a major rethink.上皮性卵巢癌的随访：亟待重大反思。
Curr Oncol Rep. 2013 Jun;15(3):204-6. doi: 10.1007/s11912-013-0310-z.
9
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.子宫内膜癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8. doi: 10.1093/annonc/mdt353.
10
[Diagnosis and treatment of recurrent epithelial ovarian carcinoma].复发性上皮性卵巢癌的诊断与治疗
Zhonghua Fu Chan Ke Za Zhi. 2003 Nov;38(11):664-6.

引用本文的文献

1
BRCA1 promoter methylation predicts PARPi response in ovarian cancer: insights from the KOMET study.BRCA1启动子甲基化预测卵巢癌对PARPi的反应：来自KOMET研究的见解
Clin Epigenetics. 2025 Aug 7;17(1):140. doi: 10.1186/s13148-025-01917-w.
2
Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study.尼拉帕利和安罗替尼治疗铂耐药卵巢癌患者的不良事件管理：II期多中心ANNIE研究的最新进展
Ther Clin Risk Manag. 2025 Jul 21;21:1135-1147. doi: 10.2147/TCRM.S526755. eCollection 2025.
3
Therapeutic effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaliplatin on ovarian cancer cell line.
白屈菜水醇提取物单独及与奥沙利铂联合对卵巢癌细胞系的治疗作用。
Discov Oncol. 2025 Jul 17;16(1):1361. doi: 10.1007/s12672-025-03081-2.
4
Are Poly (ADP-Ribose) Polymerase Inhibitors Safe in Paraneoplastic Dermatomyositis due to High-Grade Serous Carcinoma of the Ovary? A Case Report and a Review of the Literature.聚（ADP - 核糖）聚合酶抑制剂在卵巢高级别浆液性癌所致副肿瘤性皮肌炎中是否安全？一例病例报告及文献综述。
Case Rep Oncol. 2025 May 29;18(1):878-884. doi: 10.1159/000546665. eCollection 2025 Jan-Dec.
5
Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools.肿瘤基质的定量和定性指标在预测卵巢癌预后中的作用以及基于人工智能工具对其研究的拓展
Mol Ther Oncol. 2025 May 24;33(2):201001. doi: 10.1016/j.omton.2025.201001. eCollection 2025 Jun 18.
6
Cytoreductive surgery in advanced epithelial ovarian cancer: a real-world analysis guided by clinical variables, homologous recombination, and BRCA status.晚期上皮性卵巢癌的细胞减灭术：一项由临床变量、同源重组和BRCA状态指导的真实世界分析
Int J Gynecol Cancer. 2025 Jun;35(6):101809. doi: 10.1016/j.ijgc.2025.101809. Epub 2025 Apr 4.
7
GANT61 Modulates Autophagy and Lipid Metabolism in Ovarian Cancer.GANT61调节卵巢癌中的自噬和脂质代谢。
Cell Prolif. 2025 Jul;58(7):e70051. doi: 10.1111/cpr.70051. Epub 2025 May 1.
8
Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study.初始接受贝伐单抗治疗的复发性卵巢癌患者的无铂间期及后续含铂化疗疗效评估：SGSG018/国际协作组研究
Gynecol Oncol Rep. 2025 Apr 9;59:101740. doi: 10.1016/j.gore.2025.101740. eCollection 2025 Jun.
9
The Legacy of COVID-19: Hospital Fear Led to the Delayed Diagnosis of an Ovarian Tumor with Massive Ascites and Extensive Abdominal Necrosis.新冠疫情的遗留问题：医院的恐惧导致了一例伴有大量腹水和广泛腹部坏死的卵巢肿瘤的诊断延迟。
Life (Basel). 2025 Apr 11;15(4):638. doi: 10.3390/life15040638.
10
Endocrine Maintenance Therapy in High-Grade Serous Ovarian Cancer: A Retrospective Off-Label Real-World Cohort Study.高级别浆液性卵巢癌的内分泌维持治疗：一项回顾性非标签真实世界队列研究
Cancers (Basel). 2025 Apr 12;17(8):1301. doi: 10.3390/cancers17081301.